Suppr超能文献

医院中作为风险与成本管理工具的临床路径——一篇讨论文件

Clinical pathways as instruments for risk and cost management in hospitals - a discussion paper.

作者信息

Romeyke Tobias, Stummer Harald

机构信息

Dept. of Public Health, Information Systems and Health Technology Assessment UMIT - University for Health Sciences, Medical Informatics and Technology, Vienna, Austria.

出版信息

Glob J Health Sci. 2012 Feb 29;4(2):50-9. doi: 10.5539/gjhs.v4n2p50.

Abstract

INTRODUCTION

The distinctive characteristics of the German health system are medical progress and financial pressure-and this is especially true of the hospitals. These challenges must be met by strategic management instruments for quality assurance, and by reducing costs.

PURPOSE

This article presents the instrument "clinical pathway" (also known as "clinical treatment pathway") and describes the possibilities it offers, both for quality assurance and risk management, and for cost reduction. The clinical pathway presented here will be that for "multimodal pain therapy", as used in the context of acute inpatient care in Germany.

METHODS

A general presentation of the risks in hospital is followed by consideration of the risks associated with core processes. A comprehensive total cost analysis is performed for those patients who meet the pathway entry criteria and who fulfil the requirements for the structure of care provided within multimodal pain therapy.

DISCUSSION AND CONCLUSION

Multimodal pain therapy places high demands on the structural, procedural and outcome quality of the medical, nursing and therapeutic services provided, and these demands are reflected in high costs for the provision of this care. The treatment process involves many different professional groups. These complex interfaces can potentially generate risks, which can lead to the possibility of legal liability. A clinical pathway must structure the core process and then combine elements of quality assurance in order to optimise patient care and minimise risk. The examination of costs reveals significant potential savings (patients with clinical pathway: EUR 3086±212; patients without clinical pathway: EUR 3774±460; Mann-Whitney U test; p<0.001). For the managers of a hospital, the clinical pathway represents a strategic management instrument that can serve for continual cost control and cost reduction, and can contribute in the form of quality assurance towards a transparent provision of services.

摘要

引言

德国医疗体系的显著特点是医学进步和财务压力——医院尤其如此。这些挑战必须通过质量保证的战略管理手段以及降低成本来应对。

目的

本文介绍了“临床路径”(也称为“临床治疗路径”)这一手段,并描述了它在质量保证和风险管理以及降低成本方面所提供的可能性。这里介绍的临床路径将是德国急性住院护理中使用的“多模式疼痛治疗”的临床路径。

方法

首先对医院中的风险进行总体介绍,然后考虑与核心流程相关的风险。对符合路径准入标准且满足多模式疼痛治疗中所提供护理结构要求的患者进行全面的总成本分析。

讨论与结论

多模式疼痛治疗对所提供的医疗、护理和治疗服务的结构、程序和结果质量提出了很高要求,而这些要求反映在提供这种护理的高成本上。治疗过程涉及许多不同的专业群体。这些复杂的接口可能会产生风险,进而导致法律责任的可能性。临床路径必须构建核心流程,然后结合质量保证要素,以优化患者护理并将风险降至最低。成本审查显示出显著的潜在节省(采用临床路径的患者:3086±212欧元;未采用临床路径的患者:3774±460欧元;曼-惠特尼U检验;p<0.001)。对于医院管理者而言,临床路径是一种战略管理手段,可用于持续的成本控制和降低成本,并可通过质量保证的形式为透明的服务提供做出贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7ac5/4777053/ce69b3c76c4d/GJHS-4-50-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验